Summer Reading Selections: Five Must-Read Studies for Clinical Practice and Trends

Four of Our Most Inspiring Leaders Talk About the Most Important Lessons From Their Careers

A contribution by David Hayes, MD, Chief Medical Officer at BIOTRONIK Inc.

Cardiac pacemaker implantations are now routine interventions. Around three million people worldwide have a pacemaker, and every year 600,000 more receive an implant. Nevertheless, the diagnosis and procedure can look challenging for patients at first— especially patients who are athletes or enjoy being active.

Cardiac catheterization labs can be complicated workplaces when it comes to occupational safety.

Why Innovative Treatment Solutions Should Be Designed With the Nurse in Mind

After starting enrollment in 2019, Dr. Valentina Kutyifa announced the first results of the BIOTRONIK-supported BIO-LIBRA trial at the Annual Heart Rhythm Society meeting (HRS 2022).

Around 49 million people in the EU suffer from cardiovascular diseases. Here, Coronary Artery Disease (CAD) accounts for the major share of the diseases. In this context, narrowing of vessels by atherosclerotic processes is closely linked to an unhealthy lifestyle. This was also the case for the North Rhine-Westphalian deacon Rainer Beerhenke. After successful stent placement and a bypass surgery in 2021, the 58-year-old is again living life to the full and is one of the first patients to take part in the EU-funded TIMELY project, which aims to improve the range of therapies for CAD patients.

Digital Health brings opportunities to advance patient care but also new challenges. In addition to a marked increase in data volume in the clinical space and increased patient involvement in care, digital technology’s role in the care space has changed. This also allows enormous opportunities for early detection and preventing clinical problems, particularly for patients with an implanted cardiac device—when data and new digital technologies are optimally managed.

Rolf Opuchlich has been with the BIOTRONIK Quality Team since 1997. In 2020, he received his own device. Despite knowing just about everything there is to know about the defibrillator he now wears, on his first vacation after getting his implant he was still a bit restless. “I was fairly nervous that first time,” says Rolf looking back at his first flight with his ICD after implantation. “Even though I know our devices well and had everything I needed with me.”

Biotronik Employees Share Their Experiences as Relatives of Cardiac Patients

How New Strategies Move Beyond Simple AF Detection to Focus on Reducing AF Burden and Monitoring Disease Progression

Continuing a company tradition that started a decade ago, BIOTRONIK employees at the company’s headquarters mounted their bicycles in early July to race through Berlin as a team during VeloCity Berlin—an event that sees teams come together for either a 60km race or a 90km race through the German capital.

2022 has been a surprising year at times when it comes to studies of what we eat and how it affects heart health. Although there have been numerous publications looking at this relationship this year—a few stood out to us, and they may have interesting implications for our diets.

More than 1.7 million cardiac implantable electronic devices are implanted worldwide each year. Young implant wearers in particular have many questions about whether and how their life will change after the procedure. One of the most important ones: whether and to what extent they can practice sports again. Media coverage of the Danish professional soccer player Christian Eriksen, who had an ICD (implantable cardioverter-defibrillator) implanted after collapsing during an international match, has further increased interest in the interaction between cardiovascular diseases and sport.

Pioneering spirit and passion for innovation – that's what BIOTRONIK stands for. This is also shown by the company’s flagship innovations: from the first German pacemaker to the GoldTip ablation catheter, a real innovation in electrophysiology that is still the gold standard today.

Whether it’s from our engaged team at BIOTRONIK, inspiring patients, or expert physicians—one thing is clear from our most read BIOTRONIK blog stories of 2022: real stories, from real people, touch hearts.

The Findings of the MATRIX Study Could Change Clinical Practice, Says Cardiac Rhythm Expert Dr. Ignasi Anguera Camos

Biotronik’s Chief Procurement Officer Takes a Look at the New Statutory Regulations

The first patient visit to BIOTRONIK in a long while met with excitement and enthusiasm

Our colleagues from around the world show that it sometimes doesn't take much to make a difference

With 2023 upon us, BIOTRONIK employees are no exception to the kind of motivated goal-setting we often see at this time of year. Whether it’s more sports, a more mindful approach to everyday life, or to quit smoking—it’s important to have as much support as possible. That’s why BIOTRONIK’s Health Program 2023 will work to empower employees to achieve their health-related goals. 2023’s edition places a special focus on improving mental health at work, alongside the company’s work to promote physical health.

Women’s History Month is the perfect time to celebrate the incredible achievements of the women who have shaped the field of cardiology.

New Research Confirms Effective Tools to Better Protect Patients with High Stroke Risk

Prof. Anders Wanhainen Highlights New ESVS Recommendations, Advising on Suspended Personal Radiation Protection Systems for the First Time

A global company that has been making devices for 60 years and has vast experience helping patients with heart and blood vessel diseases, BIOTRONIK has expanded to the chronic pain space with BIOTRONIK Neuro.

In the midst of celebrating 60 years of service in partnership with the healthcare community, BIOTRONIK’s Electrophysiology business marked another important milestone of its own in 2023 – its 20 th anniversary.

This year is a special year for BIOTRONIK, one in which we mark sixty years of service in the healthcare community.

What began with one lifesaving mission between two students in early 1960s Berlin now spans the globe: BIOTRONIK is active in more than 100 countries.

With being able to listen in while getting something else done – such as running, commuting or cooking – podcasts offer up great ways for us to keep up with what’s going on in every field imaginable – and cardiology is no exception.

2023 was a landmark year for BIOTRONIK – not simply in name or number – but in action. The company’s 60 th year of operations was a busy one for lifesaving innovations like the Amvia pacemaker and CRT-P family and Oscar catheter, to laying the groundwork for helping a whole new community of patients with the Prospera TM spinal cord stimulation system, a BIOTRONIK first.

How One Colleague’s Act Inspires a Culture of Preparedness at BIOTRONIK

A Donation Ceremony Took Place at the Woermannkehre, on January 18, 2024

Recent Studies Reveal Optimal Levels of Physical Activity for Cardiovascular Health

Exploring the Science Behind Love's Cardiovascular Benefits

Higher quality of life, more biodiversity and a better climate – the advantages of green cities seem obvious. Green living – including breathing clean air – plays an especially crucial role for our heart health and overall well-being. On the occasion of World Environment Day, we looked at what effect air pollution has on heart health and what each of us can do to make our cities more livable.

Atrial fibrillation is the most common type of heart arrhythmia and affects about 30 million people worldwide.